5 names are moving together; 80% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. | Healthcare | +4.9% | Group member |
| TXG | 10x Genomics, Inc. | Healthcare | +9.5% | Group member |
| NTRA | Natera, Inc. | Healthcare | +0.0% | Group member |
| ADPT | Adaptive Biotechnologies Corpor | Healthcare | +1.9% | Most structurally connected |
| CAI | Caris Life Sciences, Inc. | Healthcare | -0.8% | Group member |
Cohort
5 namesParticipation
80% this sessionObserved history
1 daily buildsFiling coverage
5/5 memberscredit / rates affecting interest expense
“Interest Expense Three Months Ended March 31, Change (in thousands, except percentages) 2026 2025 $ % Interest expense $ (2,889 ) $ (2,905 ) $ 16 (1)% The nominal decrease in interest expense was attributable to a change in our assumptions regarding the timeframe in which our Purchase Agreement will be fully repaid.”
ADPT 10-Q
product pipeline / R&D affecting expense
“These decreases were partially offset by a $3.0 million increase in materials cost resulting from increased revenue sample volume, a $1.2 million increase related to higher usage of our production laboratory to process revenue samples versus research and development samples and a $1.0 million increase in shipping and handling expenses.”
ADPT 10-Q
input costs affecting expense
“The blood laboratory increase was primarily driven by an increase in materials and related testing costs of $8.1 million, an increase in labor costs of $0.7 million, and a $0.7 million increase in utilities, rent, and allocated overhead, offset by a decrease in depreciation expense of $0.8 million.”
CAI 10-Q
Healthcare Diagnostics Innovation can stay leader-led if CAI and the next software names fail to join while ADPT keeps moving.
No high-confidence filing-linked non-members are available for this group yet.
Historical cohort observations are not available yet.